Label: RYSHI SPF 50 SUNSCREEN- avobenzone 3%, homosalate 15%, octisalate 5%, octocrylene 10% stick

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 15, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • PURPOSE

    Sunscreen.

  • ACTIVE INGREDIENT

    Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%.

  • INDICATIONS & USAGE

    Helps prevent sunburn. If used as directed with other sun protection measures (see Directions) decreases the risk of skin cancer and early skin aging caused by the sun.

  • WARNINGS

    For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs.

  • KEEP OUT OF REACH OF CHILDREN

    If swallowed, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    Apply liberally 15 minutes before sun exposure. Reapply after 80 minutes of swimming or sweating, immediately after towel drying, at least every 2 hours.

    Sun Protection Measures. Spending time in the sun increased your risk of skin cancer and early skin aging. To decrease this risk, regularly use sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 am - 2 pm, wear long-sleeved shirts, pants, hats, and sunglasses. Children under 6 months: ask a doctor.

  • INACTIVE INGREDIENT

    Aloe Barbadensis Leaf Extract, BHT, Caprylic/Capric Triglyceride, Cetyl Alcohol, C12-15 Alkyl Benzoate, C15-19 Alkane, Ethylhexyl Palmitate, Fragrance, Helianthus Annuus (Sunflower) Seed Oil, Ozokerite, Paraffin, Polyester-8, Theobroma Cacao (Cocoa) Seed Butter, VP/Eicosene Copolymer.

  • PRINCIPAL DISPLAY PANEL

    LabelLabel

  • INGREDIENTS AND APPEARANCE
    RYSHI SPF 50 SUNSCREEN 
    avobenzone 3%, homosalate 15%, octisalate 5%, octocrylene 10% stick
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11822-3115
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 g
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE15 g  in 100 g
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE5 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    EICOSYL POVIDONE (UNII: XQQ9MKE2BJ)  
    CERESIN (UNII: Q1LS2UJO3A)  
    POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED) (UNII: T9296U138P)  
    ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    C15-19 ALKANE (UNII: CI87N1IM01)  
    OCTOCRYLENE (UNII: 5A68WGF6WM) 10 g  in 100 g
    ETHYLHEXYL PALMITATE (UNII: 2865993309)  
    PARAFFIN (UNII: I9O0E3H2ZE)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    SUNFLOWER OIL (UNII: 3W1JG795YI)  
    COCOA BUTTER (UNII: 512OYT1CRR)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11822-3115-143 g in 1 VIAL, PLASTIC; Type 0: Not a Combination Product07/05/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02007/05/2022
    Labeler - Rite Aid (014578892)
    Registrant - Derma Care Research Labs, LLC (116817470)
    Establishment
    NameAddressID/FEIBusiness Operations
    Derma Care Research Labs, LLC116817470manufacture(11822-3115)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!